½ÃÀ庸°í¼­
»óǰÄÚµå
1580900

¼¼°èÀÇ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Electrophysiology Lab Systems Market by Product, Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½ÃÀåÀº 2023³â 112¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â¿¡´Â 119¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.88%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 168¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ¿¡´Â ½ÉÀå ¸®µë Àå¾ÖÀÇ Áø´Ü, ¸ð´ÏÅ͸µ ¹× Ä¡·á¿¡ »ç¿ëµÇ´Â °í±Þ ÀÇ·á±â±â ¹× ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½Ã½ºÅÛÀº Ä«Å×ÅÍ ÀýÁ¦ ¹× ½ÉÀå ¹Úµ¿±â À̽İú °°Àº Ä¡·áÀÇ Á¤È®¼ºÀ» ³ôÀÌ°í ¼øÈ¯±â°ú°¡ È¿°úÀûÀ¸·Î ÀÛµ¿ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ½ÉÀå ºÎÁ¤¸ÆÀÇ À¯º´·ü Áõ°¡¿Í ¼¼°èÀÇ ³ëÈ­·Î ÀÎÇØ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü±â»ý¸®ÇÐÀû °Ë»ç(EPS)¿Í °°Àº Áø´Ü °Ë»çºÎÅÍ ½ÉÀå°ú °ü·ÃµÈ ±¤¹üÀ§ÇÑ Áúº´¿¡ ´ëÀÀÇÏ´Â Ä¡·áÀû °³ÀÔ¿¡ À̸£±â±îÁö, ÀÀ¿ëÀº ´Ù¾çÇÕ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ´Â ÁÖ·Î º´¿ø, ½ÉÀå ¼¾ÅÍ, ½ÉÀå Ä¡·áÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â ¿¬±¸ ±â°üÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ÁÖ·Î ±â¼úÀû Áøº¸, Áø´Ü¿¡¼­ ÀΰøÁö´É(AI)ÀÇ ÅëÇÕ, ³·Àº ħ½À óġ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ½ÅÈï±¹ÀÇ ÇコÄɾî ÀÎÇÁ¶ó È®´ë´Â ½ÃÀå È®´ë¸¦ À§ÇÑ ÁÖ¸ñÇÒ ¸¸ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº ÇÕ¸®ÀûÀÎ °¡°Ý°ú ÀûÀÀ¼ºÀ» °­Á¶Çϰí ÀÌ·¯ÇÑ Áö¿ª¿¡ ¸Â°Ô ¸ÂÃãÇü ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÔÀ¸·Î½á ÀÚº»À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Àü±â»ý¸® ÀåºñÀÇ °í°¡, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©, ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺°ú °°Àº °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÐ¾ß ±³Â÷ ±³À° ÇÁ·Î±×·¥ ¹× ±ÔÁ¦ ±â°ü°úÀÇ Çù·ÂÀ» ÅëÇØ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϸé ÀáÀçÀûÀÎ Àå¾Ö¹°À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀÇ °¡´É¼ºÀº ¿ÏÀü ÀÚµ¿È­ ½Ã½ºÅÛ, Çâ»óµÈ À̹ÌÁö ±â¼ú, ½Ç½Ã°£ ÀÇ»ç°áÁ¤ Áö¿øÀ» Á¦°øÇÏ´Â µ¥ÀÌÅÍ ºÐ¼® ±â´ÉÀÇ °³¹ß¿¡ ÀÖ½À´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ ¿¹Ãø ÇØ¼®°ú ¸ÂÃãÇü ÀÇ·á¿¡ °üÇÑ Á¶»ç¸¦ °è¼ÓÇÔÀ¸·Î½á ºñÁî´Ï½ºÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ¿ªÇÐÀº ¿ªµ¿ÀûÀÎ °æÀï½ÃÀåÀ̱⠶§¹®¿¡ ÀÌÇØ°ü°èÀÚµéÀº ²÷ÀÓ¾øÀÌ ¿¬±¸°³¹ß¿¡ ³ë·ÂÇÏ°í ±â¼úÀÇ Áøº¸¸¦ Ȱ¿ëÇØ¾ß ÇÕ´Ï´Ù. ÆÄÆ®³Ê½ÊÀ» Ű¿ì°í ±ÔÁ¦ Áؼö¸¦ ¿°µÎ¿¡ µÎ°í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» ¼±È£ÇÔÀ¸·Î½á ±â¾÷Àº ÀÌ ¼ºÀåÇϸ鼭µµ ¾ö°ÝÇÑ ½ÃÀå »óȲÀ» È¿°úÀûÀ¸·Î ±Øº¹ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 112¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 119¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 168¾ï 6,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 5.88%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü±â»ý¸®ÇÐ °Ë»ç½Ç¿¡ ƯȭÇÑ Çコ Äɾî ÀÎÇÁ¶ó Á¤ºñ¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • ½ÉÀå Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿Í Á¶±â Áø´ÜÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼Ó
    • ÷´Ü ½ÇÇè½Ç ½Ã½ºÅÛ¿¡ ´ëÇÑ °Ç°­ °ü¸® Á¦°ø¾÷ü¿Í ±â¼ú ±â¾÷ °£ÀÇ Àü·«Àû Á¦ÈÞ
    • °íµµÀÇ Àü±â»ý¸®ÇÐÀû óġ¿¡ ´ëÇÑ ÀǷẸÇèÀÇ Àû¿ë È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ÀÇ ºÎÁ·À¸·Î ÀÎÇØ °í±Þ Àü±â»ý¸®ÇÐ ½Ã½ºÅÛÀÇ È¿°úÀûÀÎ »ç¿ëÀÌ Á¦Çѵ˴ϴÙ.
    • Á¦ÇÑµÈ »óȯ Á¤Ã¥Àº »õ·Î¿î Àü±â»ý¸®ÇÐÀû ±â¼úÀ» äÅÃÇÏ´Â °æÁ¦Àû ½ÇÇà °¡´É¼ºÀ» Á¦ÇÑÇÕ´Ï´Ù.
  • ½ÃÀå ±âȸ
    • ÀΰøÁö´É°ú Àü±â»ý¸® ½Ã½ºÅÛÀÇ ÅëÇÕ¿¡ ÀÇÇÑ È¯ÀÚ Äɾî¿Í Áø´Ü Á¤¹ÐµµÀÇ Çõ½Å
    • ½ÉÀåÇ÷°ü °Ç°­¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀÚ±Ý ¿øÁ¶¿Í ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡°¡ Àü±â»ý¸® °Ë»ç ½ÃÀåÀ» µÞ¹Þħ
    • °í·ÉÀÚ Àα¸ Áõ°¡¿¡ ÀÇÇÑ ½ÉÇ÷°ü Áúȯ ¹× Àü±â»ý¸®ÇÐÀû Ä¡·áÀÇ ÀÌȯÀ² Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä °úÁ¦
    • Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¾÷°è ƯÀ¯ ½ÃÀå °úÁ¦

Porter's Five Forces : Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

Àü±â»ý¸®ÇÐ ½ÇÇè½Ç½Ã½ºÅÛ ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Àü±â»ý¸®ÇÐ ½ÇÇè½Ç¿¡ ƯȭÇÑ ÇコÄɾî ÀÎÇÁ¶ó °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • ½ÉÀ庴¿¡ ´ëÇÑ ÀÎÁöµµÀÇ Çâ»ó°ú Á¶±â Áø´ÜÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎ
      • °í±Þ ½ÇÇè½Ç ½Ã½ºÅÛÀ» À§ÇÑ °Ç°­ °ü¸® Á¦°ø¾÷ü¿Í ±â¼ú ±â¾÷ °£ÀÇ Àü·«Àû Çù¾÷
      • °í±Þ Àü±â»ý¸®ÇÐÀû °Ë»ç¿¡ ´ëÇÑ ÀǷẸÇè Àû¿ë È®´ë
    • ¾ïÁ¦¿äÀÎ
      • ¼÷·ÃµÈ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ·¿¡ ÀÇÇØ °íµµÀÇ Àü±â»ý¸®ÇÐ ½Ã½ºÅÛÀÇ À¯È¿ Ȱ¿ëÀÌ Á¦Çѵǰí ÀÖ´Ù
      • ÇÑÁ¤ÀûÀÎ »óȯ Á¤Ã¥¿¡ ÀÇÇØ »õ·Î¿î Àü±â»ý¸®ÇÐ ±â¼úÀ» µµÀÔÇÏ´Â °æÁ¦Àû ½ÇÇö °¡´É¼ºÀÌ Á¦ÇѵȴÙ
    • ±âȸ
      • ÀΰøÁö´É°ú Àü±â»ý¸®ÇÐ ½Ã½ºÅÛÀÇ ÅëÇÕ¿¡ ÀÇÇØ ȯÀÚ Äɾî¿Í Áø´Ü Á¤¹Ðµµ°¡ Çõ½ÅµÈ´Ù
      • ½ÉÀåÇ÷°üÀÇ °Ç°­À» À§ÇÑ Á¤ºÎÀÇ ÀÚ±Ý ¿øÁ¶¿Í ´ëó Áõ°¡¿¡ ÀÇÇØ Àü±â»ý¸®ÇÐ ¿¬±¸½Ç ½ÃÀåÀÌ È°¼ºÈ­
      • °í·ÉÀÚ Àα¸ Áõ°¡¿¡ ÀÇÇØ ½ÉÇ÷°ü ÁúȯÀ̳ª Àü±â»ý¸®ÇÐÀû °Ë»çÀÇ ¹ßº´·üÀÌ »ó½ÂÇϰí ÀÖ´Ù
    • °úÁ¦
      • 1Â÷ ½ÃÀåÀÇ °úÁ¦ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå
      • ¾÷°è ƯÀ¯ ½ÃÀå °úÁ¦ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : Á¤¹Ðµµ Çâ»ó°ú ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®À¸·Î Àü±â»ý¸®ÇÐ Áø´Ü Ä«Å×ÅÍ »ç¿ë È®´ë
    • ÀÀ¿ë : ½É¹æ¼¼µ¿ÀÇ Ä¡·á¿¡ À־ÀÇ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛÀÇ »ç¿ë Áõ°¡
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • Àü±â»ý¸®ÇÐ ÀýÁ¦ Ä«Å×ÅÍ
    • ³Ãµ¿¿ä¹ý Ä«Å×ÅÍ
    • ·¹ÀÌÀú ¾îºí·¹ÀÌ¼Ç ½Ã½ºÅÛ
    • ¸¶ÀÌÅ©·ÎÆÄ ¾îºí·¹ÀÌ¼Ç ½Ã½ºÅÛ
    • °íÁÖÆÄ(RF) ÀýÁ¦ Ä«Å×ÅÍ
  • Àü±â»ý¸®ÇÐ Áø´Ü Ä«Å×ÅÍ
    • °í±Þ EP Áø´Ü Ä«Å×ÅÍ
    • Á¾·¡ÀÇ EP Áø´Ü Ä«Å×ÅÍ
  • Àü±â»ý¸®ÇÐ ½ÇÇè½ÇÀÇ ÀåÄ¡¿Í ¼³ºñ
    • 3D ¸ÅÇÎ ½Ã½ºÅÛ
    • EP ·¹ÄÚµù ½Ã½ºÅÛ
    • EP ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç
    • EP X¼± ½Ã½ºÅÛ
    • ¸®¸ðÆ® ½ºÆ¼¾î¸µ ½Ã½ºÅÛ
  • Àü±â»ý¸®ÇÐ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ

Á¦7Àå Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • ½É¹æ¼¼µ¿
  • ½É¹æ Á¶µ¿°ú AVNRT
  • ¿ùÇÁ, ÆÄŲ½¼, È­ÀÌÆ® ÁõÈıº

Á¦8Àå Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú¿¬±¸±â°ü
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àü±â»ý¸®ÇÐ ½ÇÇè½Ç ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Stereotaxis´Â ¾×¼¼½º Æ÷ÀÎÆ® Å×Å©³î·ÎÁö½ºÀÇ Àμö¸¦ ¹ßÇ¥ÇØ, º¹ÀâÇÑ ºÎÁ¤¸Æ Ä¡·á¿Í ·Îº¿ Ç÷°ü³» ¼ö¼úÀÇ ´É·ÂÀ» °­È­ÇØ, ¼¼°è Àü°³¸¦ °èȹÇϰí ÀÖ½À´Ï´Ù.
    • ¹ÙÀÌ¿À¼¾½º À¥½ºÅÍ´Â AI ´ëÀÀ ¸ÅÇΰú Ä«Å×ÅÍ ÀýÁ¦ÀÇ Á¤¹Ðµµ¿Í È¿À²À» ³ôÀÌ´Â »õ·Î¿î ¸ðµâÀ» žÀçÇÑ CARTO 3 ½Ã½ºÅÛ ¹öÀü 8À» ¹ßÇ¥
    • GE HealthCare´Â CardioLab ½Ã½ºÅÛÀ» žÀçÇÑ Prucka 3 µðÁöÅÐ ¾ÚÇÁ¸¦ ¹ß¸ÅÇØ, ³ôÀº ½ÅÈ£ Ãæ½Çµµ¿Í ³ëÀÌÁî Àú°¨¿¡ ÀÇÇØ EP·¦ ½Ã½ºÅÛÀ» °­È­
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • AcqKnowledge by BIOPAC
  • Acutus Medical Inc.
  • Baylis Medical
  • Baylis Medical Company
  • Becton, Dickinson and Company
  • Biosense Webster Inc.
  • Biotronik
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • CathVision
  • Cook Group Incorporated
  • Dipylon Medical AB
  • EP Map Systems GmbH
  • EP Solutions SA
  • GE HealthCare Technologies Inc.
  • Hansen Medical, Inc by Auris Health
  • Imricor Medical Systems, Inc.
  • Intelesens Ltd. by CardioComm Solutions
  • Koninklijke Philips NV
  • LivaNova, plc
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Siemens Healthineers
  • St. Jude Medical by Abbott Laboratories
  • Stereotaxis, Inc.
  • Topera, Inc. by Abbott
BJH 24.11.07

The Electrophysiology Lab Systems Market was valued at USD 11.29 billion in 2023, expected to reach USD 11.92 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 16.86 billion by 2030.

Electrophysiology Lab Systems encompass advanced medical equipment and technology used to diagnose, monitor, and treat heart rhythm disorders. These systems are crucial for the effective functioning of cardiology departments, offering precision in procedures such as catheter ablation and pacemaker implantations. The necessity arises due to the growing prevalence of cardiac arrhythmias and the increasing aging population globally. Applications extend from diagnostic tests like electrophysiology studies (EPS) to therapeutic interventions addressing a broad spectrum of heart-related illnesses. End-users primarily include hospitals, cardiac centers, and research institutions aiming to enhance cardiac care quality. Market growth is primarily influenced by technological advancements, the integration of artificial intelligence (AI) in diagnostics, and a rising demand for minimally invasive procedures. The expanding healthcare infrastructure in emerging economies offers notable opportunities for market expansion. Companies can capitalize by investing in tailored solutions for these regions, focusing on affordability and adaptability. However, challenges such as the high cost of electrophysiology equipment, stringent regulatory frameworks, and the requirement for skilled professionals can impede market growth. Addressing these concerns with cross-disciplinary training programs and collaborations with regulatory bodies could mitigate potential hurdles. Innovation potential lies in the development of fully automated systems, enhanced imaging technologies, and data analytics capabilities to provide real-time decision support. Continued research in AI-driven predictive analytics and personalized medicine can propel business growth. The nature of the electrophysiology lab systems market is dynamic and competitive, requiring stakeholders to consistently engage in research and development to leverage technological advancements. By fostering partnerships, attending to regulatory compliance, and prioritizing cost-effective solutions, businesses can navigate this growing yet challenging market landscape effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 11.29 billion
Estimated Year [2024] USD 11.92 billion
Forecast Year [2030] USD 16.86 billion
CAGR (%) 5.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electrophysiology Lab Systems Market

The Electrophysiology Lab Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising investments in healthcare infrastructure development specifically for electrophysiology labs
    • Increasing awareness and early diagnosis of heart conditions driving market growth
    • Strategic collaborations between healthcare providers and technology firms for advanced lab systems
    • Expansion of medical insurance coverage for advanced electrophysiology procedures
  • Market Restraints
    • Shortage of skilled healthcare professionals limits the effective utilization of advanced electrophysiology systems
    • Limited reimbursement policies restrict the financial viability of adopting new electrophysiology technologies
  • Market Opportunities
    • Integration of artificial intelligence with electrophysiology systems revolutionizing patient care and diagnostic accuracy
    • Increased government funding and initiatives for cardiovascular health boosting electrophysiology lab market
    • Expanding geriatric population contributing to higher incidences of cardiovascular diseases and electrophysiology procedures
  • Market Challenges
    • Primary market challenges in the electrophysiology lab systems market
    • Industry-specific market challenges in the electrophysiology lab systems market

Porter's Five Forces: A Strategic Tool for Navigating the Electrophysiology Lab Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electrophysiology Lab Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electrophysiology Lab Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electrophysiology Lab Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electrophysiology Lab Systems Market

A detailed market share analysis in the Electrophysiology Lab Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electrophysiology Lab Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electrophysiology Lab Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electrophysiology Lab Systems Market

A strategic analysis of the Electrophysiology Lab Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electrophysiology Lab Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AcqKnowledge by BIOPAC, Acutus Medical Inc., Baylis Medical, Baylis Medical Company, Becton, Dickinson and Company, Biosense Webster Inc., Biotronik, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CathVision, Cook Group Incorporated, Dipylon Medical AB, EP Map Systems GmbH, EP Solutions SA, GE HealthCare Technologies Inc., Hansen Medical, Inc by Auris Health, Imricor Medical Systems, Inc., Intelesens Ltd. by CardioComm Solutions, Koninklijke Philips N.V., LivaNova, plc, Medtronic plc, MicroPort Scientific Corporation, Siemens Healthineers, St. Jude Medical by Abbott Laboratories, Stereotaxis, Inc., and Topera, Inc. by Abbott.

Market Segmentation & Coverage

This research report categorizes the Electrophysiology Lab Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices & Equipment, and Electrophysiology Monitoring Systems. The Electrophysiology Ablation Catheters is further studied across Cryoablation Catheters, Laser Ablation Systems, Microwave Ablation Systems, and Radiofrequency (RF) Ablation Catheters. The Electrophysiology Diagnostic Catheters is further studied across Advanced EP Diagnostic Catheters and Conventional EP Diagnostic Catheters. The Electrophysiology Laboratory Devices & Equipment is further studied across 3D Mapping Systems, EP Recording Systems, EP Software Solutions, EP X-Ray Systems, and Remote Steering Systems.
  • Based on Application, market is studied across Atrial Fibrillation, Atrial Flutter & AVNRT, and Wolff-Parkinson-White Syndrome.
  • Based on End User, market is studied across Academic & Research Institutes, Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising investments in healthcare infrastructure development specifically for electrophysiology labs
      • 5.1.1.2. Increasing awareness and early diagnosis of heart conditions driving market growth
      • 5.1.1.3. Strategic collaborations between healthcare providers and technology firms for advanced lab systems
      • 5.1.1.4. Expansion of medical insurance coverage for advanced electrophysiology procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of skilled healthcare professionals limits the effective utilization of advanced electrophysiology systems
      • 5.1.2.2. Limited reimbursement policies restrict the financial viability of adopting new electrophysiology technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence with electrophysiology systems revolutionizing patient care and diagnostic accuracy
      • 5.1.3.2. Increased government funding and initiatives for cardiovascular health boosting electrophysiology lab market
      • 5.1.3.3. Expanding geriatric population contributing to higher incidences of cardiovascular diseases and electrophysiology procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Primary market challenges in the electrophysiology lab systems market
      • 5.1.4.2. Industry-specific market challenges in the electrophysiology lab systems market
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding use of electrophysiology diagnostic catheters owing to improved accuracy and real-time data analytics
    • 5.2.2. Applications: Increasing use of electrophysiology lab systems for the treatment of atrial fibrillation
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electrophysiology Lab Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Electrophysiology Ablation Catheters
    • 6.2.1. Cryoablation Catheters
    • 6.2.2. Laser Ablation Systems
    • 6.2.3. Microwave Ablation Systems
    • 6.2.4. Radiofrequency (RF) Ablation Catheters
  • 6.3. Electrophysiology Diagnostic Catheters
    • 6.3.1. Advanced EP Diagnostic Catheters
    • 6.3.2. Conventional EP Diagnostic Catheters
  • 6.4. Electrophysiology Laboratory Devices & Equipment
    • 6.4.1. 3D Mapping Systems
    • 6.4.2. EP Recording Systems
    • 6.4.3. EP Software Solutions
    • 6.4.4. EP X-Ray Systems
    • 6.4.5. Remote Steering Systems
  • 6.5. Electrophysiology Monitoring Systems

7. Electrophysiology Lab Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Atrial Fibrillation
  • 7.3. Atrial Flutter & AVNRT
  • 7.4. Wolff-Parkinson-White Syndrome

8. Electrophysiology Lab Systems Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Clinics
  • 8.5. Hospitals

9. Americas Electrophysiology Lab Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Electrophysiology Lab Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Electrophysiology Lab Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Stereotaxis announces acquisition of Access Point Technologies, enhancing capabilities in complex arrhythmia treatment and robotic endovascular surgery with plans for global expansion
    • 12.3.2. Biosense Webster unveils CARTO 3 System Version 8 with AI-enabled mapping and novel modules to boost catheter ablation precision and efficiency
    • 12.3.3. GE HealthCare launches Prucka 3 Digital Amplifier with CardioLab system, enhancing EP lab systems with high signal fidelity and reduced noise
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AcqKnowledge by BIOPAC
  • 3. Acutus Medical Inc.
  • 4. Baylis Medical
  • 5. Baylis Medical Company
  • 6. Becton, Dickinson and Company
  • 7. Biosense Webster Inc.
  • 8. Biotronik
  • 9. BIOTRONIK SE & Co. KG
  • 10. Boston Scientific Corporation
  • 11. CathVision
  • 12. Cook Group Incorporated
  • 13. Dipylon Medical AB
  • 14. EP Map Systems GmbH
  • 15. EP Solutions SA
  • 16. GE HealthCare Technologies Inc.
  • 17. Hansen Medical, Inc by Auris Health
  • 18. Imricor Medical Systems, Inc.
  • 19. Intelesens Ltd. by CardioComm Solutions
  • 20. Koninklijke Philips N.V.
  • 21. LivaNova, plc
  • 22. Medtronic plc
  • 23. MicroPort Scientific Corporation
  • 24. Siemens Healthineers
  • 25. St. Jude Medical by Abbott Laboratories
  • 26. Stereotaxis, Inc.
  • 27. Topera, Inc. by Abbott
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦